| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.41B | 2.67B | 2.56B | 2.50B | 1.74B |
| Gross Profit | 794.53M | 890.14M | 852.34M | 831.42M | 447.08M |
| EBITDA | 435.25M | 544.68M | 553.59M | 555.83M | 230.92M |
| Net Income | 187.67M | 214.41M | 185.25M | 219.91M | 132.49M |
Balance Sheet | |||||
| Total Assets | 2.69B | 2.59B | 2.89B | 2.80B | 2.03B |
| Cash, Cash Equivalents and Short-Term Investments | 592.79M | 500.49M | 780.09M | 770.22M | 431.92M |
| Total Debt | 213.20M | 299.42M | 485.74M | 551.97M | 335.70M |
| Total Liabilities | 782.13M | 848.09M | 1.09B | 1.14B | 680.46M |
| Stockholders Equity | 1.65B | 1.51B | 1.45B | 1.36B | 1.23B |
Cash Flow | |||||
| Free Cash Flow | 501.62M | 219.05M | 271.39M | 273.80M | 55.96M |
| Operating Cash Flow | 575.73M | 393.41M | 484.66M | 512.51M | 105.90M |
| Investing Cash Flow | -218.39M | -155.39M | -173.76M | -176.99M | -126.00M |
| Financing Cash Flow | -275.53M | -500.90M | -286.18M | -7.94M | -44.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$955.14M | 2.38 | 11.76% | 7.86% | -9.79% | -12.85% | |
68 Neutral | HK$187.00M | 7.60 | 8.42% | 18.18% | -3.56% | -16.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$218.40M | 7.19 | -23.30% | 8.60% | -3.83% | -698.65% | |
54 Neutral | HK$174.65M | 4.19 | 10.09% | ― | -6.56% | ― | |
48 Neutral | HK$756.72M | -10.57 | -2.27% | 13.04% | -7.73% | -82.01% | |
46 Neutral | HK$58.30M | 184.81 | 0.37% | ― | -10.78% | ― |